Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kaori Sano, Akira Ainai, Tadaki Suzuki & Hideki Hasegawa. (2018) Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics. Expert Review of Vaccines 17:8, pages 687-696.
Read now
Read now
Manpreet Kaur, Samer Singh & Rakesh Bhatnagar. (2013) Anthrax vaccines: present status and future prospects. Expert Review of Vaccines 12:8, pages 955-970.
Read now
Read now
Valentina A Feodorova & Vladimir L Motin. (2012) Plague vaccines: current developments and future perspectives. Emerging Microbes & Infections 1:1, pages 1-5.
Read now
Read now
Articles from other publishers (20)
E. Diane Williamson & Petra C.F. Oyston. 2023. Plotkin's Vaccines. Plotkin's Vaccines
816
825.e4
.
Greta Van Slyke, Dylan J. Ehrbar, Jennifer Doering, Jennifer L. Yates, Ellen S. Vitetta, Oreola Donini & Nicholas J. Mantis. (2020) Endpoint and epitope-specific antibody responses as correlates of vaccine-mediated protection of mice against ricin toxin. Vaccine 38:43, pages 6721-6729.
Crossref
Crossref
E D Williamson & G E Westlake. (2019) Vaccines for emerging pathogens: prospects for licensure. Clinical and Experimental Immunology 198:2, pages 170-183.
Crossref
Crossref
Jennifer Westfall, Jennifer L. Yates, Greta Van Slyke, Dylan Ehrbar, Thomas Measey, Richard Straube, Oreola Donini & Nicholas J. Mantis. (2018) Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine. Vaccine 36:40, pages 5967-5976.
Crossref
Crossref
E. Diane Williamson & Petra C.F. Oyston. 2018. Plotkin's Vaccines. Plotkin's Vaccines
762
772.e4
.
Ronald T. TothIVIV, Siva Krishna Angalakurthi, Greta Van Slyke, David J. Vance, John M. Hickey, Sangeeta B. Joshi, C. Russell Middaugh, David B. Volkin, David D. Weis & Nicholas J. Mantis. (2017) High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine. Clinical and Vaccine Immunology 24:12.
Crossref
Crossref
Anthony L. Cunningham, Nathalie Garçon, Oberdan Leo, Leonard R. Friedland, Richard Strugnell, Béatrice Laupèze, Mark Doherty & Peter Stern. (2016) Vaccine development: From concept to early clinical testing. Vaccine 34:52, pages 6655-6664.
Crossref
Crossref
Susan Welkos, Joel A. Bozue, Nancy Twenhafel & Christopher K. Cote. 2016. The Bacterial Spore. The Bacterial Spore
269
311
.
Susan Welkos, Joel Bozue, Nancy Twenhafel & Christopher Cote. (2015)
Animal Models for the Pathogenesis, Treatment, and Prevention of Infection by
Bacillus anthracis
. Microbiology Spectrum 3:1.
Crossref
Crossref
Christopher K. Cote, Jared D. Heffron, Joel A. Bozue & Susan L. Welkos. 2015. Molecular Medical Microbiology. Molecular Medical Microbiology
1789
1844
.
Diane Williamson. (2014) Approaches to Modelling the Human Immune Response in Transition of Candidates from Research to Development. Journal of Immunology Research 2014, pages 1-6.
Crossref
Crossref
Patrik Ryden, Susan Twine, Hua Shen, Gregory Harris, Wangxue Chen, Anders Sjostedt & Wayne Conlan. (2013) Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria. Molecular Immunology 54:1, pages 58-67.
Crossref
Crossref
E D Williamson & P C F Oyston. (2013) Protecting against plague: towards a next-generation vaccine. Clinical and Experimental Immunology 172:1, pages 1-8.
Crossref
Crossref
E. Diane Williamson & Petra C.F. Oyston. 2013. Vaccines. Vaccines
493
503
.
Susan Twine, Hua Shen, Gregory Harris, Wangxue Chen, Anders Sjostedt, Patrik Ryden & Wayne Conlan. (2012) BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: Association of protection with post-vaccination and post-challenge immune responses. Vaccine 30:24, pages 3634-3645.
Crossref
Crossref
E. D. Williamson. (2012) The Role of Immune Correlates and Surrogate Markers in the Development of Vaccines and Immunotherapies for Plague. Advances in Preventive Medicine 2012, pages 1-7.
Crossref
Crossref
Petra C.F. Oyston & E. Diane Williamson. 2012. Advances in Applied Microbiology Volume 81. Advances in Applied Microbiology Volume 81
209
241
.
J Wayne Conlan. (2011) Tularemia vaccines: recent developments and remaining hurdles. Future Microbiology 6:4, pages 391-405.
Crossref
Crossref
Mara S Rocchi, Paul M Bartley, Neil F Inglis, Esther Collantes-Fernandez, Gary Entrican, Frank Katzer & Elisabeth A Innes. (2011) Selection of Neospora caninum antigens stimulating bovine CD4+ve T cell responses through immuno-potency screening and proteomic approaches. Veterinary Research 42:1, pages 91.
Crossref
Crossref
Jr-Shiuan Lin, Steven Park, Jeffrey J. Adamovicz, Jim Hill, James B. Bliska, Christopher K. Cote, David S. Perlin, Kei Amemiya & Stephen T. Smiley. (2010) TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine 29:2, pages 357-362.
Crossref
Crossref